---
title: 'Navigating new horizons: Prospects of NET-targeted radiopharmaceuticals in
  precision medicine'
date: '2024-06-10'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/38855189/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20240610182540&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: In the evolving landscape of precision medicine, NET-targeted radiopharmaceuticals
  are emerging as pivotal tools for the diagnosis and treatment of a range of conditions,
  from heart failure and neurodegenerative disorders to neuroendocrine cancers. This
  review evaluates the advancements offered by ^(18)F-labeled PET tracers and ^(211)At
  alpha-particle therapy, juxtaposed with current ^(123)I-MIBG SPECT and ^(131)I-MIBG
  therapies. The enhanced spatial resolution and capability for ...
disable_comments: true
---
In the evolving landscape of precision medicine, NET-targeted radiopharmaceuticals are emerging as pivotal tools for the diagnosis and treatment of a range of conditions, from heart failure and neurodegenerative disorders to neuroendocrine cancers. This review evaluates the advancements offered by ^(18)F-labeled PET tracers and ^(211)At alpha-particle therapy, juxtaposed with current ^(123)I-MIBG SPECT and ^(131)I-MIBG therapies. The enhanced spatial resolution and capability for ...